今日文獻聚焦於周產期精神疾病的預防策略與風險因子識別，涵蓋艾氯胺酮新型給藥方式的預防性試驗，以及經前障礙作為周產期精神疾病高危險因子的流行病學證據。
Drug design, development and therapy · Bolus versus Continuous Infusion of Esketamine for Prevention of Postpartum Depression After Caesarean Delivery: A Randomized, Double-Blind, Controlled Trial.
此隨機雙盲對照試驗直接比較艾氯胺酮兩種給藥方式於剖腹產時預防產後憱鬱症的效果，為麻醉科與產科團隊提供具臨床操作性的用藥決策依據。
BMJ open · Risk of perinatal psychiatric disorder among women with a history of premenstrual disorder: a nationwide register-based study from Sweden.
此全國性登錄研究證實經前障礙病史為周產期精神疾病之顯著風險因子，支持將該病史納入產前精神健康風險評估的臨床指引。